The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.025
Bid: 0.023
Ask: 0.028
Change: 0.00 (0.00%)
Spread: 0.005 (21.739%)
Open: 0.025
High: 0.00
Low: 0.00
Prev. Close: 0.025
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third tranche of shares issued to Venus Capital

18 Jul 2022 13:13

RNS Number : 8483S
Supply @ME Capital PLC
18 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Supply@ME Capital plc

(The "Company" or "SYME")

Share issuance and Total Voting Rights

 

Third tranche of new ordinary shares issued under equity funding facility with Venus Capital SA; new ordinary shares issued to TradeFlow directors; and to correct previous rounding issue

Capital Enhancement Plan deployment

SYME, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, today announces that it is to issue the third mandatory tranche ("Third Tranche") of new ordinary shares in the Company to Venus Capital SA ("Venus Capital"), under the key terms of the equity funding facility announced on 27 April 2022. The equity funding facility with Venus Capital forms an integral part of the Company's Capital Enhancement Plan, also announced on 27 April 2022.

The Third Tranche, comprising 1,350,000,000 new ordinary shares, will be issued at a price of 0.05 pence per share, raising gross proceeds for the Company of £675,000.

The Company will additionally issue to Venus Capital 1 warrant for every 2 ordinary shares comprised in the Third Tranche. As such, following the resolutions passed at the Company's Annual General Meeting held on 30 June 2022, the Company will issue a total of 5,585,000,000 warrants to Venus Capital in connection with the signing of the binding agreement and the issue of the first three tranches of new ordinary shares. The issue of warrants is in line with the key terms of the equity funding facility announced on 27 April 2022. The exercise price of the warrants referred to above is 0.065p with the warrants exercisable at any time up to 31 December 2025.

Additionally, with respect to the £1.95m bullet loan announced on 27 April 2022, the Company:

· has exercised its discretion to draw down £100,000 of Loan Notes in order to support its working capital needs. In this regard, the Company will continue to assess its working capital needs and may, at its own discretionary, draw down further amounts in the future;

· will issue £308,500 of Loan Notes in order to settle the over-all fees due to Venus Capital regarding the arrangement of the Capital Enhancement Plan and the three mandatory tranches of equity issues to date.

These Loan Notes are convertible into new ordinary shares with a maturity date of 31 December 2025 at a 10% p.a. interest rate.

TradeFlow acquisition related earn-out payments

The Company will issue 106,762,760 new ordinary shares to each of Tom James, Chief Executive Officer and Chief Investment Officer of TradeFlow Capital Management ("TradeFlow"), and John Collis, Chief Risk Officer and Head of Compliance at TradeFlow, who are both executive directors of SYME, in relation to settlement of post-acquisition earn out payments for the financial year ended 31 December 2021. The combined number of 213,525,520 new ordinary shares was determined by reference to a pre-determined revenue milestone, of which 80% was achieved by TradeFlow during 2021. As detailed in the Company's Annual Report and Accounts for the year ended 31 December 2021, there is an option for the Company to settle the post-acquisition earn out payments in either cash or shares and in this instance the option to settle through the issue of new ordinary shares has been chosen.

Correction of discrepancy concerning number of new ordinary shares in issue

The Company identified that a discrepancy of two ordinary share had occurred between the number reported on its share register and the number of shares in issue recorded at Companies House. This discrepancy was caused due to rounding issues and resulted in two ordinary shares being omitted from previous applications for listing. The Company is seeking to correct this discrepancy through the issue of an additional two new ordinary shares as part of the current share issue. 

Total voting rights

Applications has been made to the Financial Conduct Authority (the "FCA") and to the London Stock Exchange plc (the "London Stock Exchange") for admission of ordinary shares comprising the Third Tranche, the TradeFlow new ordinary shares and the two new ordinary shares to the standard segment of the Official List and to trading on the London Stock Exchange's main market for listed securities, respectively ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 19 July 2022.

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, that following the issue of the Third Tranche of new ordinary shares to Venus Capital, the issue of new ordinary shares to TradeFlow directors and to correct the previous discrepancy in the number of shares, the Company's issued share capital will consist of 42,352,865,472 ordinary shares of £0.00002 per share ("ordinary shares"), each with one vote. There are no shares held in Treasury. Therefore, the total number of voting rights in the Company is 42,352,865,472 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For the purposes of UK MAR, the person responsible for arranging release of this Announcement on behalf of SYME is Alessandro Zamboni, CEO.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Chanice Smith, Cicero/AMO, +44 (0)20 7947 5317; chanice.smith@cicero-group.com

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOELVLFFLDLFBBB
Date   Source Headline
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.